Pramipexole

Amber-G

Brand Name(s):Mirapexin, Mirapexin Prolonged-Release

Indication:Parkinson’s disease

Rationale:

Considered:Sep-07

Review Date:Jul-23

Comments:
Refer to Shared Care Protocol
…………………………
NICE NG71
Parkinson’s disease in adults
Jul-17…………………………Safety update 2020 – SPC now advises that abrupt discontinuation of dopaminergic therapy can lead to the development of a neuroleptic malignant syndrome or a dopamine agonist withdrawal syndrome.